How To Calculate Free Fraction Of Drug

Estimate unbound drug fraction (fu), free concentration, and bound percentage using validated pharmacokinetic formulas.

Formula references: fu = Cu/Ct, fu = (100 – %Bound)/100, or fu = 1/(1 + Ka[P]).

Expert Guide: How to Calculate Free Fraction of Drug in Clinical and Research Practice

The free fraction of a drug, usually written as fu, is one of the most important concepts in pharmacokinetics and therapeutic drug monitoring. It tells you what proportion of circulating drug is unbound to plasma proteins and therefore immediately available to distribute into tissues, interact with receptors, be metabolized, or be excreted. In practical terms, total concentration alone can be misleading when protein binding changes. Two patients can have the same total concentration, yet very different active unbound concentrations.

At the bedside and in development work, free fraction helps clinicians and pharmacologists answer key questions: Is the pharmacologically active exposure rising? Is toxicity risk increasing because albumin is low? Is measured total concentration underestimating effect? Understanding how to calculate fu correctly can prevent dosing errors, especially for highly protein-bound drugs such as warfarin, phenytoin, valproate, diazepam, and many antineoplastic agents.

Core Definitions You Need First

• Ct (total concentration): Sum of bound and unbound drug in plasma.
• Cu (unbound concentration): Free drug concentration in plasma water.
• Cb (bound concentration): Drug attached to proteins such as albumin or alpha-1 acid glycoprotein.
• fu (free fraction): Cu/Ct, usually expressed as a decimal (0.02) or percentage (2%).
• % Bound: (Cb/Ct) × 100, equivalent to (1 – fu) × 100.

The Three Most Useful Equations

1. From measured concentrations: fu = Cu / Ct
2. From reported binding percentage: fu = (100 – %Bound) / 100
3. From binding constant model: fu = 1 / (1 + Ka[P]) for a simple one-site approximation

The first equation is usually preferred in patient care when both total and unbound concentrations are available. The second is commonly used for quick estimates from prescribing information. The third is a mechanistic approximation useful for conceptual modeling and research simulations where protein concentration and affinity are known.

Step by Step Calculation Workflow

1. Confirm that concentration units are consistent for all values.
2. Choose the correct formula based on available data.
3. Compute fu as a decimal first.
4. Convert to percentage by multiplying fu × 100.
5. If needed, compute free concentration using Cu = fu × Ct.
6. Check plausibility: fu must be between 0 and 1.

Worked Example 1: Using Total and Free Concentration

Suppose a patient has total phenytoin concentration of 12 mg/L and directly measured unbound concentration of 1.2 mg/L.

• fu = Cu/Ct = 1.2/12 = 0.10
• Free fraction percentage = 0.10 × 100 = 10%
• Percent bound = 90%

Interpretation: 10% of circulating phenytoin is active and unbound. If albumin drops or displacement occurs, fu can increase even if total concentration remains similar.

Worked Example 2: Using Percent Bound

If a label reports that a drug is 98% protein bound:

• fu = (100 – 98)/100 = 0.02
• Free fraction = 2%
• If Ct = 50 ng/mL, then Cu = 0.02 × 50 = 1 ng/mL

Worked Example 3: Using Ka and Protein Concentration

Assume a simplified one-site interaction with Ka = 1.0 × 10⁵ L/mol and protein concentration [P] = 6.0 × 10^-4 mol/L.

• fu = 1/(1 + Ka[P])
• fu = 1/(1 + 100000 × 0.0006) = 1/61 = 0.0164
• Free fraction percentage is about 1.64%

This quick model demonstrates why tightly bound drugs often have very low fu and why moderate shifts in protein concentration can produce meaningful changes in active exposure.

Comparison Table: Typical Protein Binding Statistics for Common Drugs

Drug	Typical Protein Binding (%)	Approximate fu	Clinical Note
Warfarin	~99%	~0.01	Small fu changes can meaningfully alter anticoagulant effect.
Phenytoin	~90%	~0.10	Hypoalbuminemia may increase unbound exposure despite normal total level.
Valproic acid	~90 to 95%	~0.05 to 0.10	Binding is concentration dependent; fu can rise at higher total levels.
Diazepam	~98 to 99%	~0.01 to 0.02	Highly albumin bound; physiologic changes may increase active fraction.
Lidocaine	~60 to 80%	~0.20 to 0.40	Affected by alpha-1 acid glycoprotein fluctuations in acute illness.

Major Biological Factors That Change Free Fraction

• Albumin concentration: Normal adult serum albumin is typically about 3.5 to 5.0 g/dL. Lower albumin generally increases fu for acidic and neutral drugs.
• Alpha-1 acid glycoprotein (AAG): Often rises during stress, inflammation, trauma, and malignancy; can reduce fu of basic drugs.
• Renal dysfunction: Uremic toxins may displace drugs from binding sites, increasing fu.
• Liver disease: Reduced protein synthesis can elevate unbound fractions.
• Drug-drug displacement: Competing compounds can transiently change unbound concentration, especially in high extraction or narrow therapeutic index settings.
• Concentration dependence: Some drugs show saturable binding, so fu rises as concentration increases.

Method Comparison: How Unbound Drug Is Measured in the Lab

Method	Typical Turnaround	Typical Precision (CV%)	Strengths	Limitations
Equilibrium dialysis	4 to 24 hours	~5 to 15%	Reference method with strong acceptance in research and bioanalysis.	Slower workflow; nonspecific binding and stability issues must be controlled.
Ultrafiltration	15 to 60 minutes	~8 to 20%	Fast and practical for many labs.	Membrane adsorption and temperature effects can bias free concentration.
Ultracentrifugation	1 to 3 hours	~10 to 20%	Avoids membrane interactions.	Requires specialized instrumentation and careful technique.

Clinical Interpretation: Why Total Concentration Alone Can Mislead

For highly bound drugs, small shifts in binding can produce substantial relative changes in unbound concentration. Imagine a drug with fu of 1% (99% bound). If fu rises to 2%, unbound exposure doubles, even when total concentration is unchanged. In a drug with a narrow therapeutic window, that doubling can be clinically significant.

This is why many institutions interpret levels with context: albumin, renal function, inflammation markers, and co-medications. Where available, direct unbound concentration measurement is superior to corrected equations. Corrected formulas are useful screening tools but should not replace measured free levels in unstable or critically ill patients.

Practical Dosing and Monitoring Tips

1. Use direct unbound assays for high-risk drugs and high-risk patients when possible.
2. Do not compare total and unbound levels without matching collection times.
3. Interpret fu trends over time, not just isolated values.
4. Document current albumin and major interacting medications.
5. Confirm unit consistency before any calculation.
6. Recheck calculations if fu is outside 0 to 1 or if Cu exceeds Ct.

Common Errors to Avoid

• Mixing units, such as ng/mL and mg/L, without conversion.
• Assuming fixed protein binding when concentration-dependent binding is known.
• Using population average binding percentages in unstable physiology.
• Ignoring preanalytical factors such as temperature and delayed processing.
• Overinterpreting displacement interactions without considering clearance compensation.

Authoritative References and Further Reading

For evidence-based background and primary source material, review:
U.S. FDA Warfarin Label (protein binding and clinical pharmacology)
NCBI Bookshelf: Clinical Pharmacokinetics Overview
MedlinePlus: Albumin Blood Test and interpretation context

Bottom line: calculating free fraction is straightforward mathematically, but interpreting it correctly requires physiology, assay context, and drug-specific knowledge. Use fu as a dynamic clinical signal, not just a static number.